Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.36 |
| ▸ | MGLL | Q99685 | 1/20 | 0.33 |
| ▸ | LTA4H | P09960 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | HPGD | P15428 | 2/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | AR | P10275 | 1/20 | 0.31 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | GLA | P06280 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23780598 | 0.95 | ALDH1A1 (0.34) | TDP1MGLLLTA4HKDM4EALDH1A1 | |
| SCHEMBL23780604 | 0.90 | LMNA (0.32) | LMNAGLA | |
| SCHEMBL23780600 | 0.82 | LMNA (0.33) | ALDH1A1L3MBTL1LMNAGLA | |
| SCHEMBL23780591 | 0.72 | — | — | |
| SCHEMBL23780592 | 0.71 | SMN1; SMN2 (0.48) | ALDH1A1CYP1A2CYP2C9TSHR | |
| SCHEMBL23780594 | 0.69 | ALDH1A1 (0.37) | LTA4HKDM4EALDH1A1HPGDL3MBTL1 | |
| SCHEMBL23780589 | 0.69 | TSHR (0.41) | TDP1ALDH1A1L3MBTL1TSHR | |
| SCHEMBL23780601 | 0.68 | LMNA (0.33) | LMNAGLA | |
| SCHEMBL23780599 | 0.67 | ALDH1A1 (0.33) | KDM4EALDH1A1HPGDL3MBTL1HTT | |
| SCHEMBL10504247 | 0.66 | CCR10 (0.36) | KDM4EALDH1A1LMNAGLA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11685716-B2 | Plant growth inhibiting agent, and plant growth inhibiting method using same | NATIONAL UNIVERSITY CORPORATION KUMAMOTO UNIVERSITY (JP) | 2023-06-27 | — | — | US | disclosed |
| US-11685716-B2 | Plant growth inhibiting agent, and plant growth inhibiting method using same | NATIONAL UNIVERSITY CORPORATION KUMAMOTO UNIVERSITY (JP) | 2023-06-27 | — | — | US | disclosed |
| US-11685716-B2 | Plant growth inhibiting agent, and plant growth inhibiting method using same | NATIONAL UNIVERSITY CORPORATION KUMAMOTO UNIVERSITY (JP) | 2023-06-27 | — | — | US | disclosed |
| US-20220048857-A1 | PLANT GROWTH INHIBITING AGENT, AND PLANT GROWTH INHIBITING METHOD USING SAME | NATIONAL UNIVERSITY CORPORATION KUMAMOTO UNIVERSITY (JP) | 2022-02-17 | — | — | US | disclosed |
| US-20220048857-A1 | PLANT GROWTH INHIBITING AGENT, AND PLANT GROWTH INHIBITING METHOD USING SAME | NATIONAL UNIVERSITY CORPORATION KUMAMOTO UNIVERSITY (JP) | 2022-02-17 | — | — | US | disclosed |
| US-11142497-B2 | Plant growth inhibiting agent, and plant growth inhibiting method using same | NATIONAL UNIVERSITY CORPORATION KUMAMOTO UNIVERSITY (JP) | 2021-10-12 | — | — | US | disclosed |
| US-11142497-B2 | Plant growth inhibiting agent, and plant growth inhibiting method using same | NATIONAL UNIVERSITY CORPORATION KUMAMOTO UNIVERSITY (JP) | 2021-10-12 | — | — | US | disclosed |
| US-20210276950-A1 | PLANT GROWTH INHIBITING AGENT, AND PLANT GROWTH INHIBITING METHOD USING SAME | NATIONAL UNIVERSITY CORPORATION KUMAMOTO UNIVERSITY (JP) | 2021-09-09 | — | — | US | disclosed |
| US-20210276950-A1 | PLANT GROWTH INHIBITING AGENT, AND PLANT GROWTH INHIBITING METHOD USING SAME | NATIONAL UNIVERSITY CORPORATION KUMAMOTO UNIVERSITY (JP) | 2021-09-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220048857-A1 | PLANT GROWTH INHIBITING AGENT, AND PLANT GROWTH INHIBITING METHOD USING SAME | ING2, CCNA1, CCNI | TDP1 4847/4885MGLL 1700/4885LTA4H 3671/4885 |
| US-11685716-B2 | Plant growth inhibiting agent, and plant growth inhibiting method using same | ING2, CCNA1, CCNI | TDP1 4847/4885MGLL 1700/4885LTA4H 3671/4885 |
| US-11142497-B2 | Plant growth inhibiting agent, and plant growth inhibiting method using same | ING2, CCNA1, CCNI | TDP1 4847/4885MGLL 1700/4885LTA4H 3671/4885 |
| US-20210276950-A1 | PLANT GROWTH INHIBITING AGENT, AND PLANT GROWTH INHIBITING METHOD USING SAME | ING2, CCNA1, CCNI | TDP1 4847/4885MGLL 1700/4885LTA4H 3671/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.